Loading...
Jazz Pharmaceuticals plc
JAZZ•NASDAQ
Healthcare
Biotechnology
$118.23
$0.22(0.19%)
Jazz Pharmaceuticals plc (JAZZ) Financial Performance & Income Statement Overview
Review Jazz Pharmaceuticals plc’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
6.12%
↑ 6.12%
Operating Income Growth
23.86%
↑ 23.86%
Net Income Growth
35.02%
↑ 35.02%
Operating Cash Flow Growth
27.83%
↑ 27.83%
Operating Margin
14.63%
↑ 14.63%
Gross Margin
84.99%
↑ 84.99%
Net Profit Margin
11.86%
↑ 11.86%
ROE
11.90%
↑ 11.90%
ROIC
5.77%
↑ 5.77%
Jazz Pharmaceuticals plc (JAZZ) Income Statement & Financial Overview
Review Jazz Pharmaceuticals plc's (JAZZ) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.09B | $1.05B | $1.02B | $901.98M |
| Cost of Revenue | $0.00 | $111.61M | $265.13M | $251.22M |
| Gross Profit | $1.09B | $943.36M | $758.70M | $650.77M |
| Gross Profit Ratio | $1.00 | $0.89 | $0.74 | $0.72 |
| R&D Expenses | $128.71M | $199.92M | $220.73M | $222.85M |
| SG&A Expenses | $369.29M | $325.77M | $338.52M | $351.71M |
| Operating Expenses | $897.40M | $683.15M | $559.26M | $574.56M |
| Total Costs & Expenses | $897.40M | $794.76M | $824.38M | $825.78M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $51.26M | $58.70M | $62.02M | $66.12M |
| Depreciation & Amortization | $0.00 | $164.53M | $163.03M | $163.38M |
| EBITDA | $190.77M | $424.74M | $362.48M | $268.53M |
| EBITDA Ratio | $0.18 | $0.40 | $0.35 | $0.27 |
| Operating Income | $190.77M | $260.21M | $199.44M | $76.21M |
| Operating Income Ratio | $0.18 | $0.25 | $0.19 | $0.08 |
| Other Income/Expenses (Net) | -$57.55M | -$59.40M | -$61.52M | -$67.81M |
| Income Before Tax | $133.22M | $200.81M | $137.93M | -$1.60M |
| Income Before Tax Ratio | $0.12 | $0.19 | $0.13 | -$0.002 |
| Income Tax Expense | -$57.90M | -$14.53M | -$30.65M | $11.67M |
| Net Income | $191.12M | $215.06M | $168.57M | -$14.62M |
| Net Income Ratio | $0.18 | $0.20 | $0.16 | -$0.02 |
| EPS | $3.16 | $3.52 | $2.68 | -$0.23 |
| Diluted EPS | $3.11 | $3.42 | $2.42 | -$0.23 |
| Weighted Avg Shares Outstanding | $60.54M | $61.41M | $62.88M | $62.54M |
| Weighted Avg Shares Outstanding (Diluted) | $61.50M | $63.17M | $69.63M | $62.54M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan